Adoption of Pathologic Complete Response as a Surrogate End...

  • Main
  • 2016 / 11
  • Adoption of Pathologic Complete Response as a Surrogate End...

Adoption of Pathologic Complete Response as a Surrogate End Point in Neoadjuvant Trials in HER2-Positive Breast Cancer Still an Open Question

Burzykowski, Tomasz, Saad, Everardo D., Buyse, Marc
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
JAMA Oncology
DOI:
10.1001/jamaoncol.2016.3941
Date:
November, 2016
File:
PDF, 37 KB
english, 2016
Conversion to is in progress
Conversion to is failed